HealthcareNSE · BSE

Dr. Lal Pathlabs Limited

LALPATHLAB · ISIN INE600L01024

Share price

₹1,701▲ +5.24%

Market capitalisation

₹28396 Cr● Closed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹28396 Cr

Current price

₹1,701

+5.24% today

52W high

₹1,803

52W low

₹1,273

Stock P/E

53.7

P/B ratio

11.33

02 · Per share & returns

EPS (TTM)

₹31.67

Book value

₹150

ROE

21.48%

ROA

13.23%

Dividend yield

0.87%

Beta

0.19

03 · Financials (TTM)

By the numbers

Revenue

₹2763 Cr

+16.60% YoY

EBITDA

₹782 Cr

Net profit

₹505 Cr

-15.40% YoY

Profit margin

18.27%

Operating margin

20.24%

Total debt

₹199 Cr

Total cash

₹1332 Cr

Debt / equity

0.08x

Current ratio

3.48x

Payout ratio

39.52%

04 · Analyst view

Target price

₹1,686

Upside

-0.86%

Consensus

BUY

Analysts

05 · Shareholding pattern

Who owns LALPATHLAB?

Promoters
53.21%
Founders & promoter group
Institutions
31.09%
FII + DII
Public
15.70%
Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol: LALPATHLAB
Exchange: NSE · BSE
CIN: —
ISIN: INE600L01024
BSE code: 539524
Sector: Healthcare
Industry: Healthcare
Face value: ₹10
Listing date: 22 Dec 2015
Employees: —
Headquarters: Gurugram, India
Website: www.lalpathlabs.com

07 · About

What is Dr. Lal Pathlabs Limited?

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.

08 · Common questions

Frequently asked

What is the CIN of Dr. Lal Pathlabs Limited?+

The Corporate Identity Number for Dr. Lal Pathlabs Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Dr. Lal Pathlabs Limited?+

Promoter holding in LALPATHLAB is approximately 53.21%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Dr. Lal Pathlabs Limited?+

Dr. Lal Pathlabs Limited (LALPATHLAB) has a market capitalisation of approximately ₹28396 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent